HIV 1+2 (Ag/Ab)

The HIV 1+2 (Ag/Ab) analysis is an innovative diagnostic test that provides accurate detection of HIV infection in its early stages, combining the ability to identify the p24 antigen and specific antibodies of the virus. When early detection is crucial, this analysis becomes an indispensable tool in the fight against the spread of HIV, providing individuals with valuable information about their health status. If you want to be sure of your HIV status or suspect possible exposure to the virus, we recommend undergoing this test. For those seeking highly professional service, IntroLab laboratory in Belgrade offers scheduling for this analysis with complete discretion and expertise.

What is the HIV 1+2 (Ag/Ab) analysis and why is it performed?

The HIV 1+2 (Ag/Ab) analysis is used when there is a need for early detection of HIV infection. Due to its ability to detect both the p24 antigen and antibodies, the test can identify infection earlier than most other available tests. It is recommended in situations where a person believes they may have been exposed to HIV, such as through unprotected sexual contact, sharing needles, or potential exposure to contaminated blood. It is also useful for healthcare workers who may have been exposed to needle injuries or other work-related injuries.

The HIV 1+2 (Ag/Ab) analysis is often used in screening pregnant women to identify and treat infections early, reducing the risk of transmission to the child. This test is also valuable in emergency medical situations, such as urgent surgeries, where a quick assessment of HIV status may be crucial.

When is the HIV 1+2 (Ag/Ab) test performed?

After exposure to HIV, the p24 antigen typically becomes detectable within 10 to 14 days. However, there are variations in the timeframe when the antigen can be detected, depending on the individual’s immune response and the amount of virus they were exposed to.

After potential exposure to HIV, it is recommended to test with the HIV 1+2 (Ag/Ab) analysis as early as 2 to 4 weeks after possible contact. Although the test can show a positive result as early as 10 days after exposure, waiting 2 to 4 weeks increases the likelihood of accurately detecting the infection. While the HIV 1+2 (Ag/Ab) test is very sensitive and can detect infection early, it should be repeated after a few months to confirm the initial result and ensure diagnostic accuracy.

What is HIV?

The Human Immunodeficiency Virus (HIV) is an RNA virus from the Retroviridae family, specifically the Lentiviridae subfamily. This virus primarily targets the human immune system, effectively reducing the body’s ability to fight infections and diseases. One of the primary characteristics of retroviruses, such as HIV, is their ability to convert their RNA into DNA. This conversion allows the virus to integrate into the host’s genetic material and continue replicating.

HIV differs from many other viruses due to its complex composition. Its genome is protected by a protein shell known as the p24 capsid protein. Additionally, the virus is surrounded by a lipoprotein envelope that is crucial for its life cycle. On the surface of this envelope are specific glycoproteins, such as gp41 and gp120, which play a key role in the virus’s binding and entry into host cells.

While HIV can cause various symptoms and complications, its most serious consequence is Acquired Immunodeficiency Syndrome (AIDS). This condition occurs when the human immune system becomes so weakened that it cannot resist other infections or diseases. It is important to understand the difference: while HIV is the virus that infects a person, AIDS is a condition that can result from prolonged and untreated HIV infection.

How is it transmitted?

The Human Immunodeficiency Virus is transmitted through contact with infected bodily fluids. The most common modes of transmission include:

• Unprotected sexual intercourse (vaginal, anal, and to a lesser extent, oral) with a person infected with HIV.
• Sharing needles or syringes.
• Blood transfusion or receiving infected blood products.
• From mother to child during childbirth or breastfeeding.
• Using non-sterilized medical equipment.

HIV is not transmitted through everyday social contact, such as handshakes, hugs, kisses, or sharing food and drinks.

Infectivity of bodily fluids in the context of HIV

HIV can be detected in various bodily fluids, but not all of them transmit the virus with the same efficiency. The concentration of HIV in bodily fluids is directly related to the risk of virus transmission.

High infectivity:

• Blood: One of the main transmission routes, especially through sharing needles or transfusion.
• Semen: Infected semen can transmit HIV during sexual contact.
• Vaginal fluids: Can transmit HIV during sexual contact.
• Breast milk: Risk of transmission from mother to child during breastfeeding.

Low or no infectivity:

• Saliva: Although it may contain traces of HIV, the risk of transmission is extremely low.
• Tears: Low concentration of the virus, considered safe.
• Sweat: Contains very low to no concentration of HIV and is not a transmission route.

Symptoms of infection

HIV infection manifests through various symptoms that can change over time as the disease progresses.

• Flu-like symptoms: fever, headache, fatigue, sore throat
• Swollen lymph glands
• Rash
• Joint or muscle pain
• Night sweats
• Nausea, vomiting, or diarrhea
• Weight loss
• Dry cough
• Oral infections such as candidiasis
• Recurrent herpes infections

More advanced stages can lead to neurological problems such as confusion, lethargy, and difficulty walking. Some people may not experience symptoms for years after infection. Regular testing and monitoring of health status are crucial for those who may have been at risk of infection.

How is it treated?

HIV cannot currently be completely cured, but it can be controlled with antiretroviral therapy (ART). ART is a combination of medications that prevent the virus from replicating in the body. When taken regularly and according to a doctor’s instructions, these medications can reduce the amount of HIV in the blood to undetectable levels, allowing infected individuals to live long and healthy lives. By reducing viral load, ART also reduces the risk of transmitting HIV to others. Although antiretroviral therapy does not eliminate the virus from the body, it can prevent or delay the development of AIDS, thereby reducing the risk of some serious diseases and infections. It is important for people with HIV to regularly visit their doctor and adhere to the prescribed therapy to maintain optimal health and prevent complications.

Preparation for HIV 1+2 (Ag/Ab) analysis?

No special preparation is required for the HIV 1+2 (Ag/Ab) analysis. Staying hydrated and informing the laboratory staff of any medications you are taking are recommended. The sample collection involves venipuncture to draw blood.